- Date:
February 2022 - Client:
Basic Pharma - Sector:
Pharmaceutical - Service:
Sell-side advisory
Basic Pharma sells its stake in Geleen-based Pharmalot Compounding
As of 24 February 2022 Basic Pharma sold its 50% stake in Pharmalot Compounding to Ace Compounding, a subsidiary of the Zeewolde-based company Ace Holding. This merger will make Ace Holding a larger and stronger player in the pharmacy preparation market with a large sales channel.
Pharmalot is the wholesale compounding pharmacy that Basic Pharma and Mosadex jointly set up and further developed into a highly successful formula. Pharmalot supplies a niche range of compounded drugs to 800 pharmacies and dispensing physicians across the Netherlands.
The sale of Pharmalot Compounding to Ace Compounding will allow Basic Pharma to intensify its focus on growing its core activities relating to the development and manufacture of medicines and the provision of services to the pharmaceutical industry. ‘In addition, Basic Pharma and Ace intend to work together on quality control, product development and manufacturing of medicines as both firms possess a great deal of complementary knowledge in these areas,’ explains Bob Kool, CEO of Basic Pharma.
Synergy in the pharmacy preparation sector. Ace’s objective for the takeover of Pharmalot is to strengthen its market position. Basic Pharma and Mosadex, the current shareholders of Pharmalot, are convinced that concentrating pharmacy preparation activities within Ace will help guarantee continuity and optimise opportunities to develop these activities.
Orange Corporate Finance acted as advisor to the seller.
Basic Pharma
Basic Pharma is an independent group of pharmaceutical firms focusing on the development, licensing, manufacturing and commercialisation of pharmaceutical and biopharmaceutical products (including clinical trial medications). It also provides a wide range of services to the pharmaceutical industry such as quality control, regulatory services, pharmacovigilance services, quality services and project management/support during the product development process.
Ace Compounding
Ace Compounding is a joint venture owned by Ace Holding, the parent company of Ace Pharmaceuticals and Mosadex Groep. For the past 30 years, the Zeewolde-based firm Ace has been delivering tailored pharmaceuticals for specific patient needs: registered medications, clinical trial medications and prescription medications. Since 2020, the firm has also provided ad hoc compounded medications from stock as well as ad hoc compounded medications.
Mosadex Groep
Via its twelve subsidiaries, full-service pharmaceutical firm Mosadex Groep has been serving over 800 independent public pharmacies to facilitate optimal business operations, distribution of medications and medical aids, pharmaceutical treatment/self-treatment and digitisation. Its characteristically cooperative structure ensures Mosadex Groep and its subsidiaries are closely involved in the sector and know exactly what is going on in the market at all times.
